Martina Schneider

5.7k total citations · 2 hit papers
108 papers, 3.3k citations indexed

About

Martina Schneider is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Martina Schneider has authored 108 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Martina Schneider's work include Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cytomegalovirus and herpesvirus research (7 papers). Martina Schneider is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cytomegalovirus and herpesvirus research (7 papers). Martina Schneider collaborates with scholars based in Germany, Switzerland and France. Martina Schneider's co-authors include Kai‐Uwe Goss, Stefan Baumgartner, Elisabeth Stafflinger, Cornelis J.P. Grimmelikhuijzen, Frank Hauser, Laurent Lagrost, Ferdi Grawe, Elisabeth Knust, André S. Bachmann and Metin Sitti and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Martina Schneider

103 papers receiving 3.2k citations

Hit Papers

A Tissue Adhesion‐Controllable and Biocompatible Small‐Sc... 2022 2026 2023 2024 2022 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Tissue Adhesion‐Controllable and Biocompatible Small‐Scale Hydrogel Adhesive Robot
    2022 150 citations Martina Schneider, Metin Sitti et al. profile →
  2. Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
    2023 94 citations Martina Schneider et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martina Schneider Germany 29 1.1k 532 432 412 334 108 3.3k
Satoru Shimizu Japan 37 1.1k 1.0× 290 0.5× 236 0.5× 752 1.8× 454 1.4× 349 4.8k
Nobuo Suzuki Japan 35 1.6k 1.5× 284 0.5× 314 0.7× 230 0.6× 230 0.7× 434 5.6k
Peter Hutzler Germany 40 2.3k 2.1× 363 0.7× 457 1.1× 346 0.8× 232 0.7× 83 6.0k
Yasuhiko Ohta Japan 35 1.0k 0.9× 534 1.0× 221 0.5× 541 1.3× 105 0.3× 233 4.7k
Xiaolin He China 35 1.7k 1.5× 623 1.2× 507 1.2× 183 0.4× 189 0.6× 85 4.2k
Manuela Malatesta Italy 34 2.0k 1.8× 425 0.8× 241 0.6× 344 0.8× 392 1.2× 218 4.6k
Stephen Brown United Kingdom 35 1.8k 1.7× 530 1.0× 260 0.6× 198 0.5× 122 0.4× 165 5.6k
Kristian Pfaller Austria 31 851 0.8× 182 0.3× 325 0.8× 246 0.6× 253 0.8× 79 3.3k
Ludwig Jonas Germany 28 818 0.8× 163 0.3× 192 0.4× 522 1.3× 278 0.8× 130 2.7k
Nan Jiang China 39 2.8k 2.6× 207 0.4× 515 1.2× 514 1.2× 428 1.3× 223 6.6k

Countries citing papers authored by Martina Schneider

Since Specialization
Citations

This map shows the geographic impact of Martina Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Schneider more than expected).

Fields of papers citing papers by Martina Schneider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Schneider. The network helps show where Martina Schneider may publish in the future.

Co-authorship network of co-authors of Martina Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Schneider. A scholar is included among the top collaborators of Martina Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Schneider. Martina Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Schneider, Martina, et al.. (2023). Substances from unregulated drug markets – A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland). International Journal of Drug Policy. 114. 103972–103972. 8 indexed citations
4.
Wang, Tianlu, Mingtong Li, Meng Li, et al.. (2022). Adaptive wireless millirobotic locomotion into distal vasculature. Nature Communications. 13(1). 4465–4465. 106 indexed citations
5.
6.
Mark, Michael, Sylvie Rusakiewicz, Martin Früh, et al.. (2022). Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study. ESMO Open. 7(3). 100446–100446. 5 indexed citations
7.
Schneider, Martina, et al.. (2020). Novel approach for discrimination of eosinophilic granulocytes and evaluation of their surface receptors in a multicolor fluorescent histological assessment. SHILAP Revista de lepidopterología. 92(2). 99–106. 8 indexed citations
8.
Shah, Rajiv, Laura V. Klotz, Manuel Feißt, et al.. (2020). 1912TiP NICITA: Nivolumab with chemotherapy in pleural mesothelioma after surgery. Annals of Oncology. 31. S1083–S1083. 1 indexed citations
9.
Dircksen, Heinrich, Susanne Neupert, Reinhard Predel, et al.. (2011). Genomics, Transcriptomics, and Peptidomics ofDaphnia pulexNeuropeptides and Protein Hormones. Journal of Proteome Research. 10(10). 4478–4504. 156 indexed citations
10.
Schneider, Martina & Kai‐Uwe Goss. (2011). Prediction of the water sorption isotherm in air dry soils. Geoderma. 170. 64–69. 89 indexed citations
11.
Yatsenko, Andriy S., Mariya M. Kucherenko, Karin A. Fischer, et al.. (2009). The conserved WW-domain binding sites in Dystroglycan C-terminus are essential but partially redundant for Dystroglycan function. BMC Developmental Biology. 9(1). 18–18. 10 indexed citations
12.
Schneider, Martina, Ashraf A. Khalil, Joanna Poulton, et al.. (2006). Perlecan and Dystroglycan act at the basal side of the Drosophila follicular epithelium to maintain epithelial organization. Development. 133(19). 3805–3815. 98 indexed citations
13.
Zak, Zoulika, Thomas Gautier, Laure Dumont, et al.. (2004). Effect of cholesteryl ester transfer protein (CETP) expression on diet-induced hyperlipidemias in transgenic rats. Atherosclerosis. 178(2). 279–286. 9 indexed citations
14.
Deng, Wu-Min, Martina Schneider, Richard L. Frock, et al.. (2002). Dystroglycan is required for polarizing the epithelial cells and the oocyte in Drosophila. Development. 130(1). 173–184. 147 indexed citations
15.
Zak, Zoulika, Laurent Lagrost, Thomas Gautier, et al.. (2002). Expression of simian CETP in normolipidemic Fisher rats has a profound effect on large sized apoE-containing HDL. Journal of Lipid Research. 43(12). 2164–2171. 20 indexed citations
16.
Sciandra, Francesca, Martina Schneider, Bruno Giardina, et al.. (2001). Identification of the β‐dystroglycan binding epitope within the C‐terminal region of α‐dystroglycan. European Journal of Biochemistry. 268(16). 4590–4597. 40 indexed citations
17.
Schneider, Martina, et al.. (2000). Perlecan domain V of Drosophila melanogaster. European Journal of Biochemistry. 267(11). 3149–3159. 74 indexed citations
18.
Conroy, Thierry, P Cappelaere, Michel Fabbro, et al.. (1994). Acute Antiemetic Efficacy and Safety of Dolasetron Mesylate, A 5-HT3 Antagonist, in Cancer Patients Treated with Cisplatin. American Journal of Clinical Oncology. 17(2). 97–102. 36 indexed citations
19.
Hurteloup, P, P. Armand, Martina Schneider, et al.. (1989). Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. European Journal of Cancer and Clinical Oncology. 25(3). 423–428. 12 indexed citations
20.
Schwarzenberg, L, G Mathé, M. Hayat, et al.. (1969). [A new combination of methotrexate and folinic acid for cancer treatment (acute leukemia and solid tumors)].. PubMed. 77(11). 385–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satoru Shimizu Breakdown of academic impact, for papers by Nobuo Suzuki Breakdown of academic impact, for papers by Peter Hutzler Breakdown of academic impact, for papers by Yasuhiko Ohta Breakdown of academic impact, for papers by Xiaolin He Breakdown of academic impact, for papers by Manuela Malatesta Breakdown of academic impact, for papers by Stephen Brown Breakdown of academic impact, for papers by Kristian Pfaller Breakdown of academic impact, for papers by Ludwig Jonas Breakdown of academic impact, for papers by Nan Jiang
Rankless by CCL
2026